Published in Clin Gastroenterol Hepatol on August 16, 2012
Screening for Prostate Cancer in Older Patients (PLCO Screening Trial) | NCT00002540
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54
High-definition white-light (HDWL) colonoscopy and higher adenoma detection rate and the potential for paradoxical over surveillance. Dig Dis Sci (2014) 1.40
Colorectal cancer screening--optimizing current strategies and new directions. Nat Rev Clin Oncol (2013) 1.35
Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol (2014) 0.86
Adenoma detection rate in patients younger than 50 years of age: relationship of the adenoma detection rate to interval cancer. Ann Coloproctol (2015) 0.79
Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J (2017) 0.78
Efficacy and cost-effectiveness of screening colonoscopy according to the adenoma detection rate. United European Gastroenterol J (2015) 0.77
Gastroenterology and medical informatics: an evolving collaboration for quality improvement. Clin Gastroenterol Hepatol (2012) 0.75
Continuous quality improvement of colorectal cancer screening. World J Gastrointest Pharmacol Ther (2013) 0.75
Quality of colonoscopy in an emerging country: A prospective, multicentre study in Russia. United European Gastroenterol J (2016) 0.75
Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 11.76
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med (2006) 10.52
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology (2004) 2.55
Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol (2010) 2.34
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst (2005) 2.27
Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures. Gastrointest Endosc (2012) 1.96
Effect of institution-wide policy of colonoscopy withdrawal time > or = 7 minutes on polyp detection. Gastroenterology (2008) 1.86
Adenoma detection rate: the real indicator of quality in colonoscopy. Dis Colon Rectum (2008) 1.33
Developing a natural language processing application for measuring the quality of colonoscopy procedures. J Am Med Inform Assoc (2011) 1.28
Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Gastrointest Endosc (2012) 1.18
Variability in flexible sigmoidoscopy performance among examiners in a screening trial. Clin Gastroenterol Hepatol (2005) 1.13
Variation in colonoscopic technique and adenoma detection rates at an academic gastroenterology unit. Dig Dis Sci (2009) 1.12
Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. Clin Gastroenterol Hepatol (2003) 0.95
Some diminutive colorectal polyps can be removed and discarded without pathological examination. Endoscopy (2010) 0.89
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst (2012) 11.91
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA (2003) 3.82
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int (2008) 3.51
Utilization of surveillance colonoscopy in community practice. Gastroenterology (2009) 3.33
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst (2010) 3.16
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst (2005) 2.82
Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer (2005) 2.79
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77
Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc (2005) 2.63
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc (2009) 2.55
Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst (2010) 2.50
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst (2011) 2.31
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst (2005) 2.27
Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev (2009) 2.20
Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet (2008) 1.96
Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures. Gastrointest Endosc (2012) 1.96
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med (2009) 1.94
Informed decision-making and colorectal cancer screening: is it occurring in primary care? Med Care (2008) 1.75
Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res (2002) 1.65
The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol (2008) 1.61
Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol (2008) 1.58
Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58
Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res (2005) 1.57
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med (2014) 1.56
Retracted Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer. Clin Cancer Res (2008) 1.51
Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap? Am J Gastroenterol (2011) 1.48
Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev (2006) 1.46
PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J Clin Invest (2011) 1.43
Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2008) 1.42
Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening. Arch Intern Med (2009) 1.41
MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study. Cancer Prev Res (Phila) (2012) 1.39
Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial. Arch Intern Med (2008) 1.30
Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst (2010) 1.29
Yield of advanced adenoma and cancer based on polyp size detected at screening flexible sigmoidoscopy. Gastroenterology (2006) 1.29
Developing a natural language processing application for measuring the quality of colonoscopy procedures. J Am Med Inform Assoc (2011) 1.28
Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2008) 1.27
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst (2012) 1.27
Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis. Proc Natl Acad Sci U S A (2010) 1.26
Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2004) 1.20
Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Gastrointest Endosc (2012) 1.18
Diagnostic yield and clinical outcomes of capsule endoscopy. Gastrointest Endosc (2004) 1.17
Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med (2015) 1.17
Aberrant crypt foci: what we know and what we need to know. Clin Gastroenterol Hepatol (2007) 1.16
Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2004) 1.16
Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest Endosc (2002) 1.16
Variability in flexible sigmoidoscopy performance among examiners in a screening trial. Clin Gastroenterol Hepatol (2005) 1.13
Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol (2005) 1.13
Using the transtheoretical model to stage screening behavior for colorectal cancer. Health Educ Behav (2003) 1.11
A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol (2009) 1.08
Identification of nuclear matrix protein alterations associated with human colon cancer. Cancer Res (2002) 1.08
Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. Cancer Res (2006) 1.06
Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. J Thorac Oncol (2009) 1.03
Retracted Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers. Cancer Res (2007) 1.03
Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med (2015) 1.02
Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc (2011) 1.02
Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial. J Urol (2006) 1.01
The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol (2007) 0.99
Identification of calreticulin as a nuclear matrix protein associated with human colon cancer. J Cell Biochem (2003) 0.99
The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. J Natl Cancer Inst (2013) 0.98
Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial. Am J Gastroenterol (2010) 0.96
Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr Cancer (2008) 0.96
Genome-wide search for gene-gene interactions in colorectal cancer. PLoS One (2012) 0.96
Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol (2013) 0.95
Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. Clin Gastroenterol Hepatol (2003) 0.95
Cancer in inflammatory bowel disease. An evidence-based analysis and guide for physicians and patients. Gastroenterol Clin North Am (2002) 0.95
Prevalence of adenocarcinoma at esophagectomy for Barrett's esophagus with high grade dysplasia. J Gastrointest Oncol (2011) 0.94
Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. Am J Clin Nutr (2004) 0.93
Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut (2013) 0.92
Short- and long-term risk of colorectal adenoma recurrence among whites and blacks. Gastrointest Endosc (2013) 0.92
Relationship of visceral adipose tissue to recurrence of adenomatous polyps. Am J Gastroenterol (2004) 0.92
Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer (2002) 0.91
Design and utilization of the colorectal and pancreatic neoplasm virtual biorepository: An early detection research network initiative. J Pathol Inform (2010) 0.90
Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2005) 0.89
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention. Cancer Prev Res (Phila) (2011) 0.89
Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci. Gastrointest Endosc (2009) 0.89
Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans? Curr Opin Gastroenterol (2009) 0.88
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. Int J Cancer (2011) 0.88
Insulin resistance-related genes and advanced left-sided colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2007) 0.87
Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer. Mol Immunol (2009) 0.86
Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis (2007) 0.86
Association of physical activity and visceral adipose tissue in older women and men. Obes Res (2002) 0.86
Antioxidant supplementation and cancer prevention. JAMA (2009) 0.85
Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2013) 0.84
Genetic variants of adiponectin and risk of colorectal cancer. Int J Cancer (2014) 0.84
Adenomatous polyp recurrence and physical activity in the Polyp Prevention Trial (United States). Cancer Causes Control (2002) 0.84
Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps. J Cell Biochem (2004) 0.84